The company doesn’t directly benefit from tariffs. Instead, the stock benefits from the disruptions tariffs are going to ...

Cantor Fitzgerald analysts renewed their criticism of U.S. Health Secretary Robert F. Kennedy Jr. on Thursday, saying the ...

The White House has declared the controversy around a Signal chat for a military strike that inadvertently included a ...

The Cantor Fitzgerald analysts said in a note that Robert F. Kennedy Jr. was "undermining the trusted leadership of health ...

Biotech analysts urge Trump administration to replace RFK Jr. as HHS head after FDA leader's resignation. Read more here.

HHS cannot be led by an anti-vax, conspiracy theorist with inadequate training,” said analysts at investment firm Cantor ...

Fintel reports that on April 3, 2025, Cantor Fitzgerald upgraded their outlook for Zscaler (NasdaqGS:ZS) from Neutral to ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at ...

Research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Bradmer Pharmaceuticals in a note issued to investors on Monday, March 31st. Cantor Fitzgerald analyst B.

Cantor Fitzgerald says Tesla (TSLA) pre-announced that it delivered 336,681 vehicles in Q1, below the Bloomberg consensus of ...

Fintel reports that on March 31, 2025, Cantor Fitzgerald initiated coverage of Okta (NasdaqGS:OKTA) with a Overweight ...

Cantor Fitzgerald analyst Deepak Mathivanan reiterated a Buy rating on Meta Platforms (META – Research Report) yesterday and set a price target ...